Dr Lucy Oldfield MSc., PhD., AFHEA

Personal Statement

Lucy is a senior postdoctoral researcher in the department of Molecular and Clinical Cancer Medicine at the University of Liverpool. She holds a PhD in Analytical Chemistry from the University of West Virginia, an MSc in Forensic and Analytical Chemistry from the University of Strathclyde and an MSc in Chemistry from the University of Manchester. Her work for the past several years has focused on biomarker development for early detection of pancreatic cancer, especially using proteomics techniques. Lucy is interested in the relationship between pancreatic cancer and diabetes, including the mechanisms underpinning the development of diabetes in individuals with pancreatic cancer.

Lucy leads a Cancer Research UK Primer award using aptamer technology to explore the proteome in pancreatic cancer and diabetes and is a Co-Investigator on the CRUK UK-Early Detection Initiative for Pancreatic Cancer (UK-EDI), established to detect pancreatic cancer earlier in individuals with new-onset diabetes mellitus. Her other funded projects involve the creation of risk stratification tools for pancreatic cancer using health record data combined with molecular profiling, and the use of multifunctional targeted nanoparticles for MR imaging enhancement of pre-malignant pancreatic lesions.